DE69226448D1 - Glykoprotein komplexe und glykoproteine - Google Patents
Glykoprotein komplexe und glykoproteineInfo
- Publication number
- DE69226448D1 DE69226448D1 DE69226448T DE69226448T DE69226448D1 DE 69226448 D1 DE69226448 D1 DE 69226448D1 DE 69226448 T DE69226448 T DE 69226448T DE 69226448 T DE69226448 T DE 69226448T DE 69226448 D1 DE69226448 D1 DE 69226448D1
- Authority
- DE
- Germany
- Prior art keywords
- glycoprotein complex
- glycoproteine
- diseases
- medicaments
- lymphocytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77712191A | 1991-10-16 | 1991-10-16 | |
US96140492A | 1992-10-15 | 1992-10-15 | |
PCT/US1992/008878 WO1993008215A1 (en) | 1991-10-16 | 1992-10-15 | Secreted mac-2-binding glycoprotein |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69226448D1 true DE69226448D1 (de) | 1998-09-03 |
DE69226448T2 DE69226448T2 (de) | 1999-04-08 |
Family
ID=27119280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69226448T Expired - Fee Related DE69226448T2 (de) | 1991-10-16 | 1992-10-15 | Glykoprotein komplexe und glykoproteine |
Country Status (8)
Country | Link |
---|---|
US (4) | US5965382A (de) |
EP (1) | EP0625990B1 (de) |
JP (2) | JP2718827B2 (de) |
AT (1) | ATE169028T1 (de) |
AU (1) | AU673810B2 (de) |
CA (1) | CA2121256C (de) |
DE (1) | DE69226448T2 (de) |
WO (1) | WO1993008215A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9408573D0 (en) * | 1994-04-29 | 1994-06-22 | Gatsby Charitable Foundation | Identification, production and use of saponin gylcosyl hydrolases |
WO2001065928A1 (en) * | 2000-03-09 | 2001-09-13 | Yves Chicheportiche | A method for increasing the in vitro production of cystic embryoid bodies from mammalian embryonic stem cells |
AU2001265039B2 (en) * | 2000-05-26 | 2007-03-29 | Board Of Trustees Of The University Of Illinois | Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
ES2288358B1 (es) * | 2005-07-01 | 2008-11-16 | Proyecto De Biomedicina Cima, S.L. | Marcadores de fibrosis. |
US7858363B2 (en) * | 2006-07-22 | 2010-12-28 | Zymo Research Corporation | Plasmid DNA isolation |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
CN107541790B (zh) * | 2016-06-24 | 2021-07-06 | 上海交通大学 | 一种糖基化检测的人凝集素/类人凝集素芯片及制备方法 |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US20220348900A1 (en) * | 2019-08-14 | 2022-11-03 | Modernatx, Inc. | Processes for purifying downstream products of in vitro transcription |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5304636A (en) * | 1987-04-14 | 1994-04-19 | Boehringer Ingelheim International Gmbh | Receptor for the human rhinovirus minor group |
US5169936A (en) * | 1989-04-14 | 1992-12-08 | Biogen, Inc. | Protein purification on immobilized metal affinity resins effected by elution using a weak ligand |
IT1239719B (it) * | 1990-04-23 | 1993-11-15 | Univ Degli Studi Annunzio | Uso dell'anticorpo monoclonale sp-2 nella diagnostica clinica ed il monitoraggio del progredire dell'infezione hiv |
JPH06201699A (ja) * | 1990-04-23 | 1994-07-22 | Consiglio Nazi Ricerche | 臨床診断及びhiv感染進行のモニタリングに対するsp−2モノクローナル抗体の使用 |
US5422265A (en) * | 1990-12-07 | 1995-06-06 | State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The Oregon Health Sciences University | DNA sequence for the human dopamine receptor D4 and expression thereof in mammalian cells |
WO1993016183A1 (en) * | 1992-02-07 | 1993-08-19 | The Board Of Trustees Of The Leland Stanford Jr. University | Cyclophilin associated membrane proteins dna sequences |
US5492899A (en) * | 1994-01-10 | 1996-02-20 | Abbott Laboratories | Infant nutritional formula with ribo-nucleotides |
-
1992
- 1992-10-15 AT AT92922804T patent/ATE169028T1/de not_active IP Right Cessation
- 1992-10-15 JP JP5507843A patent/JP2718827B2/ja not_active Expired - Lifetime
- 1992-10-15 CA CA002121256A patent/CA2121256C/en not_active Expired - Fee Related
- 1992-10-15 AU AU28963/92A patent/AU673810B2/en not_active Withdrawn - After Issue
- 1992-10-15 WO PCT/US1992/008878 patent/WO1993008215A1/en active IP Right Grant
- 1992-10-15 EP EP92922804A patent/EP0625990B1/de not_active Expired - Lifetime
- 1992-10-15 DE DE69226448T patent/DE69226448T2/de not_active Expired - Fee Related
-
1994
- 1994-09-29 US US08/316,714 patent/US5965382A/en not_active Expired - Fee Related
-
1995
- 1995-06-07 US US08/473,673 patent/US6069127A/en not_active Expired - Fee Related
- 1995-06-07 US US08/473,791 patent/US5736340A/en not_active Expired - Fee Related
- 1995-06-07 US US08/477,674 patent/US5644035A/en not_active Expired - Fee Related
-
1997
- 1997-06-18 JP JP9161725A patent/JPH10110000A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0625990A1 (de) | 1994-11-30 |
US5736340A (en) | 1998-04-07 |
JPH10110000A (ja) | 1998-04-28 |
AU673810B2 (en) | 1996-11-28 |
DE69226448T2 (de) | 1999-04-08 |
CA2121256C (en) | 2002-05-28 |
US6069127A (en) | 2000-05-30 |
WO1993008215A1 (en) | 1993-04-29 |
US5965382A (en) | 1999-10-12 |
US5644035A (en) | 1997-07-01 |
ATE169028T1 (de) | 1998-08-15 |
AU2896392A (en) | 1993-05-21 |
JP2718827B2 (ja) | 1998-02-25 |
JPH06510790A (ja) | 1994-12-01 |
CA2121256A1 (en) | 1993-04-29 |
EP0625990B1 (de) | 1998-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68929551D1 (de) | Menschliche DNase | |
ES2186684T3 (es) | Ppeptidos antimicrobianos de neutrofilos bovinos. | |
DE3583293D1 (de) | Lymphadenopathie-assoziierte huellenantigene und deren verwendungen. | |
NO891705D0 (no) | Anti-t-celle reseptordeterminanter som autoimmunsykdomsbehandling. | |
ATE88900T1 (de) | Konjugate von interferon alpha mit immunglobulinen. | |
ATE113475T1 (de) | Hybride prokoagulierende proteine. | |
DE68916693D1 (de) | Molekular-Diagnose von Alzheimer-Krankheit. | |
DE3877753D1 (de) | Transformierender wachstumsfaktor-beta. | |
CA2079881A1 (fr) | Sequences nucleotidiques codant pour des regions variables de chaines .beta. des recepteurs des lymphocytes t humains, segments peptidiques correspondants et les applications diagnostiques et therapeutiques | |
DE69226448T2 (de) | Glykoprotein komplexe und glykoproteine | |
GB2255093A (en) | Hiv-1 core protein fragments | |
CA2000913A1 (en) | Family of high affinity antibodies for cancer treatment | |
AU4727889A (en) | A novel purified thrombomodulin-like glycoprotein obtained from urine. | |
ATE54826T1 (de) | Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung. | |
ATE202599T1 (de) | Mit isoliertem empfindlichem x-syndrom verbundene dns-sequenzen | |
ATE208630T1 (de) | Arzneimittel zur immuntherapie, enthaltend antikörper, die spezifisch das mhcii-antigen eines zu behandelnden patienten erkennen | |
FI953093A0 (fi) | Menetelmiä, joilla voidaan havaita ja hoitaa yksilöitä, joilla on epänormaaleja soluja, jotka ekspressoivat HLA-A2/tyrosinaasi-peptidiantigeenejä | |
HU902004D0 (en) | New trombolitic preparations | |
NO921883L (no) | Protein-c-inneholdende legemiddel | |
ES2115582T3 (es) | Preparacion y aplicaciones de interferon-gamma. | |
ATE58478T1 (de) | Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom. | |
FI854839A0 (fi) | Vaccin eller diagnostisk produkt erhaollen fraon peptid, samt daeri anvaendbar polypeptid. | |
EP0315081A3 (en) | Anti-coagulating protein pp4-x, its preparation and use | |
FR2636953B1 (fr) | Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques | |
GHOBRIAL | IMMUNE COMPETENCE IN END-STAGE RENAL DISEASE PATIENTS MAINTAINED BY CHRONIC HEMODIALYSIS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US |